These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 37446638)

  • 1. Novel Isosteviol-Based FXa Inhibitors: Molecular Modeling, In Silico Design and Docking Simulation.
    Gackowski M; Madriwala B; Studzińska R; Koba M
    Molecules; 2023 Jun; 28(13):. PubMed ID: 37446638
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel Thiourea and Oxime Ether Isosteviol-Based Anticoagulants: MD Simulation and ADMET Prediction.
    Gackowski M; Jędrzejewski M; Medicharla SS; Kondabala R; Madriwala B; Mądra-Gackowska K; Studzińska R
    Pharmaceuticals (Basel); 2024 Jan; 17(2):. PubMed ID: 38399378
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel Anthranilamide-Based FXa Inhibitors: Drug Design, Synthesis and Biological Evaluation.
    Wang W; Yuan J; Fu X; Meng F; Zhang S; Xu W; Xu Y; Huang C
    Molecules; 2016 Apr; 21(4):491. PubMed ID: 27089317
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design, synthesis, and biological activity of novel tetrahydropyrazolopyridone derivatives as FXa inhibitors with potent anticoagulant activity.
    Sun X; Hong Z; Liu M; Guo S; Yang D; Wang Y; Lan T; Gao L; Qi H; Gong P; Liu Y
    Bioorg Med Chem; 2017 May; 25(10):2800-2810. PubMed ID: 28389110
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and evaluation of anthranilamide-based derivatives as FXa inhibitors.
    Huang C; Wang W; Li Y; Zhang S; Meng F; Xu W; Yuan J; Chen L
    Oncotarget; 2017 Jun; 8(23):37186-37199. PubMed ID: 28415603
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantitative Structure-Activity Relationship Analysis of Isosteviol-Related Compounds as Activated Coagulation Factor X (FXa) Inhibitors.
    Gackowski M; Szewczyk-Golec K; Mądra-Gackowska K; Pluskota R; Koba M
    Nutrients; 2022 Aug; 14(17):. PubMed ID: 36079779
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design, synthesis and biological evaluation of novel 2,3-dihydroquinazolin- 4(1H)-one derivatives as potential fXa inhibitors.
    Xing J; Yang L; Yang Y; Zhao L; Wei Q; Zhang J; Zhou J; Zhang H
    Eur J Med Chem; 2017 Jan; 125():411-422. PubMed ID: 27689724
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Structure Based Study of Selective Inhibition of Factor IXa over Factor Xa.
    Kundu S; Wu S
    Molecules; 2021 Sep; 26(17):. PubMed ID: 34500804
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Innovative Three-Step Microwave-Promoted Synthesis of
    Santana-Romo F; Lagos CF; Duarte Y; Castillo F; Moglie Y; Maestro MA; Charbe N; Zacconi FC
    Molecules; 2020 Jan; 25(3):. PubMed ID: 31979319
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An integration strategy combined progressive multivariate statistics with anticoagulant activity evaluation for screening anticoagulant quality markers in Chinese patent medicine.
    Du KZ; Cui Y; Chen S; Yang R; Shang Y; Wang C; Yan Y; Li J; Chang YX
    J Ethnopharmacol; 2022 Apr; 287():114964. PubMed ID: 34990765
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and biological evaluation of Isosteviol derivatives as FXa inhibitors.
    Shi Y; Pan BW; Li WC; Wang Q; Wu Q; Pan M; Fu HZ
    Bioorg Med Chem Lett; 2020 Jan; 30(2):126585. PubMed ID: 31859158
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of AcAP5 as a novel factor Xa inhibitor with both direct and allosteric inhibition.
    Zhu Y; Lin Y; Liu X; Hu W; Wang Y
    Biochem Biophys Res Commun; 2017 Jan; 483(1):495-501. PubMed ID: 28007598
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular modeling studies of [6,6,5] Tricyclic Fused Oxazolidinones as FXa inhibitors using 3D-QSAR, Topomer CoMFA, molecular docking and molecular dynamics simulations.
    Xu C; Ren Y
    Bioorg Med Chem Lett; 2015 Oct; 25(20):4522-8. PubMed ID: 26343829
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel FXa Inhibitor Identification through Integration of Ligand- and Structure-Based Approaches.
    Lagos CF; Segovia GF; Nuñez-Navarro N; Faúndez MA; Zacconi FC
    Molecules; 2017 Sep; 22(10):. PubMed ID: 28937618
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of a novel selective factor Xa inhibitor, DJT06001, which reduces thrombus formation with low risk of bleeding.
    Hu X; Xiao Y; Yu C; Zuo Y; Yang W; Wang X; Gu B; Li J
    Eur J Pharmacol; 2018 Apr; 825():85-91. PubMed ID: 29475063
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Advances in the Development of Novel Factor Xa Inhibitors: A Patent Review.
    Khadse AN; Sharma MK; Murumkar PR; Rajput SJ; Yadav MR
    Mini Rev Med Chem; 2018; 18(16):1332-1353. PubMed ID: 29692238
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of anthranilamide derivatives as potential factor Xa inhibitors: drug design, synthesis and biological evaluation.
    Xing J; Yang L; Li H; Li Q; Zhao L; Wang X; Zhang Y; Zhou M; Zhou J; Zhang H
    Eur J Med Chem; 2015 May; 95():388-99. PubMed ID: 25839438
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A rapid pro-hemostatic approach to overcome direct oral anticoagulants.
    Thalji NK; Ivanciu L; Davidson R; Gimotty PA; Krishnaswamy S; Camire RM
    Nat Med; 2016 Aug; 22(8):924-32. PubMed ID: 27455511
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Investigation of the tight binding mechanism of a new anticoagulant DD217 to factor Xa by means of molecular docking and molecular dynamics.
    Shulga DA; Tserkovnikova NA; Tarasov DN; Tovbin DG
    J Biomol Struct Dyn; 2023 Jul; 41(10):4723-4734. PubMed ID: 35532097
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis of 3,4-diaminobenzoyl derivatives as factor Xa inhibitors.
    Yang J; Su G; Ren Y; Chen Y
    Eur J Med Chem; 2015 Aug; 101():41-51. PubMed ID: 26114810
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.